Madrid, Spain.
Genmab is strengthening its presence in Europe and expanding its commercial capabilities to bring innovative medicines to more patients. As pioneers in antibody biology and innovation, we are seeking a driven and talented individual to help deliver our cutting-edge oncology treatments to patients across Spain. If you’re passionate about oncology, bring experience from both large pharmaceutical organizations and nimble biotech environments, and with a deep expertise of the Spanish market access & pricing landscape, we want to hear from you!
The Role Genmab is preparing to launch a new innovation in cervical cancer in Europe. In this role, you will lead development of the Spanish Market Access strategy for the company’s oncology pipeline. Specifically, the Market access strategy, pricing and public affairs director will lead efforts in assessing and communicating to internal and external stakeholders the market access requirements of Spain for oncology, contributing to and shaping the overall value strategy for our brands throughout lifecycle. The position will drive development of local market access strategy, delivery of HTA submissions, and lead P&R negotiations. In this role, the director will have also to develop and implement a strong public affairs plan in collaboration with the General Manager.
Responsibilities
- Identify, analyse, develop, and implement recommendations and strategies regarding P&R policy and challenges important to company’s product portfolio;
- Analyse, synthesize, and translate technical P&R information, including coverage and reimbursement policies, into meaningful decision points, recommendations, and strategic tactics;
- Champion the P&R requirements for Spanish Commercial Operations throughout commercialization and ensure alignment between all stakeholders internally as to prioritized needs;
- Contribute to strategy discussions and communication efforts with relevant external stakeholders including key government agencies and organizations;
- Partner in development of European and global value access & pricing deliverables, working in close collaboration with European and global colleagues and external vendors as needed;
- Drive development of Spanish market access deliverables including HTA submissions; local evidence generation plans; negotiation strategies, and country-level regional and local market access tactics to secure reimbursement;
- Develop HTA payer and advocacy engagement plans and other external experts;
- Maintain alignment of local market access strategy to European and Global Market Access Strategy; establish pricing position within EU Price Brand;
- Collaborate closely with relevant internal stakeholders, including Marketing, Medical Affairs, Regulatory, etc.
Requirements
- 10 to 15 years of experience within the field of Market Access & pricing. Experience in Health Economics and Outcomes Research is a plus;
- Strong network of relevant stakeholders in Spain;
- Strong knowledge of the market access & pricing landscape;
- Strong oncology market knowledge from a commercial and clinical studies perspective;
- Excellent communication and negotiation skills;
- Business fluency in English;
- Fluency in local language is a must.
The proposed gross annual base salary range for this position, in the primary location, based on a full time schedule is: EUR84.000,00—126.000,00
The final salary offer will depend on several factors, including your skills, qualifications, and experience. In addition to base salary, this position is eligible for additional forms of compensation, such as discretionary bonuses and long-term incentives. When you join Genmab, you become a part of a culture that supports your physical, financial, social, and emotional well-being. Our benefits include, but are not limited to:
- Pension
- Health insurance and wellness benefits
- Paid time off
- Employee support programs
Further details on eligibility for compensation and benefits based on the role will be provided during the recruitment process.
This job is posted by Genmab.
This link brings you to the website of Genmab.
Si prega di menzionare che avete trovato la posizione tramite EuropeanHealthEconomics.com. Grazie e buona fortuna!
